In drug development, you must know more than science.
NGN Capital
JAFCO
NLV Partners
Bio*One Capital
NovaQuest







Asahi Kasei Pharma Corporation

Partners

We plan to grow Artisan and expand our product portfolio by forging alliances with highly strategic partners. This approach is exemplified by our relationship with Asahi Kasei Pharma Corporation (AKP). Here, we are leveraging the advanced clinical development progress and approval submission that AKP has made in Japan with our lead product, ART 123, to maximize the product's potential value in non-Asian markets. Likewise, progress we make outside of AKP territories will serve to bolster and validate the product within AKP territories.

Through similarly strategic relationships, we are seeking to build our product portfolio with other corporate partners. If you would like to learn more about partnering with Artisan, please contact us at 508-663-2150 or info@artisanpharma.net.

Asahi Kasei Pharma Corporation

Headquartered in Tokyo, AKP is a research-based health care innovator that discovers, develops, manufactures and markets products for the pharmaceutical, pharmaceutical intermediate, diagnostics, biopharmaceutical/biological filtration, medical device, medical nutrition and contact lens markets. AKP is a wholly owned business unit of Asahi Kasei Corporation, a US$12 billion technology company that provides innovative, science-based solutions to a diverse range of markets, including chemicals and plastics, apparel, housing and construction, health care and electronics.